Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

There is an unspoken precedent within the medical community: don't do anything to alienate your patients, and keep your political opinions to yourself. There are -- of course -- exceptions, but as a ...

Open science does more than improve reproducibility. It enables a decentralized AI ecosystem where public institutions, ...

Maertens reported relationships with F2G, Cidara, Pfizer, Gilead, MSD, Takeda, Mundipharma, Basilea, and Shionogi. Co-authors ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

Manav Midha is an MD candidate at the Icahn School of Medicine at Mount Sinai and a researcher at the USC Schaeffer Center ...

An often cited example of the importance of including a wide sample of patients is research showing that certain drugs can be ...

Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in adults with alkaptonuria, Cycle ...

Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) ...